Guru Ownership Trend
Guru Analysis for Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $17.15 M.
Top institutional holders include Steven Cohen and Stanley Druckenmiller.
Institutional sentiment is currently Bullish. This is evidenced by a $12.38 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 12.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Olema Pharmaceuticals, Inc. (OLMA)
Major holders include Steven Cohen ($13.4 M), Stanley Druckenmiller ($12.34 M), Ken Fisher ($3.71 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.44 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $12.38 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited OLMA. The total reported sell value was $180,556.79.
Yes, 0 managers opened new positions in OLMA, and 2 increased their existing holdings. The total reported buy value was $12.56 M.